| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $0.3259 ▲ +2.03% | Yesterday | $0.3167 ▼ -0.85% | Tomorrow's Outlook Therapeutics Inc. Common Stock (OTLK) setup is anchored to $0.3194 and targets $0.3259 (+2.03%). The near-term read is upside; watch $0.3290 / $0.3098 because daily realized volatility is about 8.00%. |
Tomorrow's Outlook Therapeutics Inc. Common Stock (OTLK) setup is anchored to $0.3194 and targets $0.3259 (+2.03%). The near-term read is upside; watch $0.3290 / $0.3098 because daily realized volatility is about 8.00%. | ||||
| Week | $0.3396 ▲ +6.31% | Last Week | $0.3109 ▼ -2.65% | The 7-day Outlook Therapeutics Inc. Common Stock model moves from $0.3109 to $0.3396 (+6.31%). It gives upside momentum context for this stock, so breaks around $0.3290 / $0.3098 matter more than a single tick. |
The 7-day Outlook Therapeutics Inc. Common Stock model moves from $0.3109 to $0.3396 (+6.31%). It gives upside momentum context for this stock, so breaks around $0.3290 / $0.3098 matter more than a single tick. | ||||
| Month | $0.3624 ▲ +13.45% | Last Month | $0.3014 ▼ -5.65% | The 1-month Outlook Therapeutics Inc. Common Stock target is $0.3624 (+13.45%), compared with the live reference near $0.3194. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Outlook Therapeutics Inc. Common Stock target is $0.3624 (+13.45%), compared with the live reference near $0.3194. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $0.3965 ▲ +24.14% | Last Year | $0.2870 ▼ -10.14% | The 1-year Outlook Therapeutics Inc. Common Stock scenario points to $0.3965 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Outlook Therapeutics Inc. Common Stock scenario points to $0.3965 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $0.4765 ▲ +49.20% | 5 Years Ago | $0.2534 ▼ -20.66% | The 5-year Outlook Therapeutics Inc. Common Stock view is $0.4765 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Outlook Therapeutics Inc. Common Stock view is $0.4765 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $0.3194 | Mid |
| Daily Change | -13.68% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 85% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $0.3194 | Daily Change | -13.68% |
| Market Cap | $27.03M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.